These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 19443233

  • 21. Synthesis and biodistribution of a new (99m) Tc-oxo complex with deoxyglucose dithiocarbamate for tumor imaging.
    Lin X, Jin Z, Ren J, Pang Y, Zhang W, Huo J, Wang X, Zhang J, Zhang Y.
    Chem Biol Drug Des; 2012 Mar; 79(3):239-45. PubMed ID: 22136603
    [Abstract] [Full Text] [Related]

  • 22. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
    Qi CM, Guo XF, Zhang HB, Li B, Jin W, Dai M.
    Yao Xue Xue Bao; 2002 Jul; 37(7):522-6. PubMed ID: 12914321
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and evaluation of [99mTcN]2+ core and [99mTcO]3+ core labeled complexes with 4-nitroimidazole xanthate derivative for tumor hypoxia imaging.
    Ruan Q, Zhang X, Gan Q, Fang S, Zhang J.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127582. PubMed ID: 33002601
    [Abstract] [Full Text] [Related]

  • 24. Radiosynthesis and biodistribution of (99m)Tc-rifampicin: a novel radiotracer for in-vivo infection imaging.
    Shah SQ, Khan AU, Khan MR.
    Appl Radiat Isot; 2010 Dec 15; 68(12):2255-60. PubMed ID: 20538473
    [Abstract] [Full Text] [Related]

  • 25. Preparation and in vivo evaluation of (99m)TcN-tertiary butyl xanthate as a potential myocardial agent.
    Mathur A, Mallia MB, Subramanian S, Banerjee S, Sarma HD, Kothari K, Venkatesh M.
    Appl Radiat Isot; 2006 Jun 15; 64(6):663-7. PubMed ID: 16436328
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups.
    Liu S, He Z, Hsieh WY, Kim YS.
    Nucl Med Biol; 2006 Apr 15; 33(3):419-32. PubMed ID: 16631092
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.
    Bu L, Li R, Jin Z, Wen X, Liu S, Yang B, Shen B, Chen X.
    Mol Imaging Biol; 2011 Feb 15; 13(1):121-7. PubMed ID: 20458635
    [Abstract] [Full Text] [Related]

  • 28. Preparation and biodistribution of 99mTc-tricarbonyl complex with 4-[(2-methoxyphenyl)piperazin-1-yl]-dithioformate as a potential 5-HT1A receptor imaging agent.
    Zhang X, Zhou P, Liu J, Huang Y, Lin Y, Chen Y, Gu T, Yang W, Wang X.
    Appl Radiat Isot; 2007 Mar 15; 65(3):287-92. PubMed ID: 17074495
    [Abstract] [Full Text] [Related]

  • 29. [Synthesis of new N3S pseudo-peptide complexes and biodistribution in mice].
    Qi CM, Guo XF, Zhang HB, Li B, Feng SJ, Yang LC.
    Yao Xue Xue Bao; 2002 Jun 15; 37(6):428-32. PubMed ID: 12579798
    [Abstract] [Full Text] [Related]

  • 30. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
    Hoffend J, Linke G, Mohammed A, Tiefenbacher CP, Eisenhut M, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2003 Apr 15; 30(4):494-501. PubMed ID: 12574972
    [Abstract] [Full Text] [Related]

  • 31. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
    Bolzati C, Cavazza-Ceccato M, Agostini S, Tokunaga S, Casara D, Bandoli G.
    J Nucl Med; 2008 Aug 15; 49(8):1336-44. PubMed ID: 18632814
    [Abstract] [Full Text] [Related]

  • 32. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A.
    Bioconjug Chem; 2007 Aug 15; 18(6):1924-34. PubMed ID: 17929883
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and biodistribution of a novel (⁹⁹m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging.
    Zhang S, Zhang W, Wang Y, Jin Z, Wang X, Zhang J, Zhang Y.
    Bioconjug Chem; 2011 Mar 16; 22(3):369-75. PubMed ID: 21319731
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, characterization and pre-clinical evaluation of (99m) Tc-tricarbonyl complexes as potential myocardial perfusion imaging agents.
    Ellis BL, Gorshkov NI, Lumpov AA, Miroslavov AE, Yalfimov AN, Gurzhiy VV, Suglobov DN, Braddock R, Adams JC, Smith AM, Prescott MC, Sharma HL.
    J Labelled Comp Radiopharm; 2013 Dec 16; 56(14):700-7. PubMed ID: 24339008
    [Abstract] [Full Text] [Related]

  • 35. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
    Giglio J, Patsis G, Pirmettis I, Papadopoulos M, Raptopoulou C, Pelecanou M, León E, González M, Cerecetto H, Rey A.
    Eur J Med Chem; 2008 Apr 16; 43(4):741-8. PubMed ID: 17658668
    [Abstract] [Full Text] [Related]

  • 36. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
    Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M.
    Q J Nucl Med Mol Imaging; 2007 Mar 16; 51(1):16-23. PubMed ID: 17372569
    [Abstract] [Full Text] [Related]

  • 37. Radiolabeling and evaluation of a novel [99mTcN]2+ complex with deferoxamine dithiocarbamate as a potential agent for bacterial infection imaging.
    Jiang Y, Fang S, Zhang X, Feng J, Ruan Q, Zhang J.
    Bioorg Med Chem Lett; 2021 Jul 01; 43():128102. PubMed ID: 33984471
    [Abstract] [Full Text] [Related]

  • 38. Pharmacology study of the neutral myocardial imaging agent technetium-99m-N(NOEt)2.
    Fang P, Wang BC, Wu CY, Wan WX, Jiang NY, Zhou X, Chen ZP.
    J Nucl Med Technol; 1999 Mar 01; 27(1):54-6. PubMed ID: 10322579
    [Abstract] [Full Text] [Related]

  • 39. From symmetrical to asymmetrical nitrido phosphino-thiol complexes: a new class of neutral mixed-ligand (99m)Tc compounds as potential brain imaging agents.
    Bolzati C, Benini E, Cavazza-Ceccato M, Cazzola E, Malago E, Agostini S, Tisato F, Refosco F, Bandoli G.
    Bioconjug Chem; 2006 Mar 01; 17(2):419-28. PubMed ID: 16536474
    [Abstract] [Full Text] [Related]

  • 40. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.